Vanguard Group’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$168K Sell
48,117
-599
-1% -$4.05K ﹤0.01% 4129
2025
Q3
$447K Buy
48,716
+10,357
+27% +$78.1K ﹤0.01% 3977
2025
Q2
$242K Buy
38,359
+1,972
+5% +$15.4K ﹤0.01% 4059
2025
Q1
$298K Hold
36,387
﹤0.01% 3993
2024
Q4
$409K Hold
36,387
﹤0.01% 3990
2024
Q3
$702K Hold
36,387
﹤0.01% 3879
2024
Q2
$819K Buy
36,387
+6,053
+20% +$181K ﹤0.01% 3859
2024
Q1
$1.56M Sell
30,334
-879
-3% -$48.8K ﹤0.01% 3669
2023
Q4
$2.2M Sell
31,213
-20,332
-39% -$1.4M ﹤0.01% 3567
2023
Q3
$3.79M Sell
51,545
-57,932
-53% -$6.01M ﹤0.01% 3357
2023
Q2
$16.4M Buy
109,477
+72,726
+198% +$10.1M ﹤0.01% 2678
2023
Q1
$1.95M Sell
36,751
-9,055
-20% -$544K ﹤0.01% 3678
2022
Q4
$4.21M Sell
45,806
-1,578
-3% -$342K ﹤0.01% 3388
2022
Q3
$10.9M Sell
47,384
-3,324
-7% -$831K ﹤0.01% 2918
2022
Q2
$9.43M Buy
50,708
+2,107
+4% +$587K ﹤0.01% 3020
2022
Q1
$19M Buy
48,601
+5,790
+14% +$1.74M ﹤0.01% 2804
2021
Q4
$15.1M Buy
+42,811
New +$20.4M ﹤0.01% 2987

Other funds holding PIII

Vanguard Group's PIII Position: Q4 2025 in Review

Vanguard Group reduced its P3 Health Partners (PIII) stake by 1.2% in Q4 2025, selling an estimated $4.05K and leaving 48,117 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #4129.

Vanguard Group first reported a position in PIII in Q4 2021 and has held it in 17 quarters since. The position peaked at $19M in Q1 2022. 13 funds tracked by Wall St. Rank hold PIII as of Q4 2025.

  • Vanguard Group held 48,117 shares of P3 Health Partners worth $168K as of Q4 2025.
  • Vanguard Group sold 599 P3 Health Partners shares in Q4 2025, an estimated $4.05K.
  • P3 Health Partners made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4129 holding.
  • Vanguard Group first reported a position in P3 Health Partners in Q4 2021 and has held it in 17 quarters since.
  • Vanguard Group's P3 Health Partners position peaked at $19M in Q1 2022.
  • 13 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.